Heat shock proteins HSP70 and GP96: structural insights

Cancer Immunol Immunother. 2006 Mar;55(3):339-46. doi: 10.1007/s00262-005-0020-y. Epub 2005 Jul 20.


Several heat shock proteins (HSPs) act as potent adjuvants for eliciting anti-tumor immunity. HSP-based tumor vaccine strategies have been highly successful in animal models and are undergoing testing in clinical trials. It is generally accepted that HSPs, functioning as chaperones for tumor antigens, elicit tumor-specific adaptive immune responses. HSPs also appear to induce innate immune responses in an antigen-independent fashion. Innate responses generated by HSPs may contribute to anti-tumor immunity. Immunologically active chaperones with anti-tumor activity are referred to as "immunochaperones". Here, we review the studies that address the role of structural domains or regions of the immunochaperones HSP70 and GP96 that may be involved in the induction of adaptive or innate immune responses.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Animals
  • Cancer Vaccines / immunology
  • HSP70 Heat-Shock Proteins / chemistry*
  • HSP70 Heat-Shock Proteins / immunology*
  • Humans
  • Membrane Glycoproteins / chemistry*
  • Membrane Glycoproteins / immunology*
  • Neoplasms / immunology*
  • Structure-Activity Relationship


  • Cancer Vaccines
  • HSP70 Heat-Shock Proteins
  • Membrane Glycoproteins
  • endoplasmin